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Immunoglobulin gene rearrangement during mammalian B cell development generally follows 
an ordered progression, beginning with heavy (H) chain genes and proceeding through x and 
~, light (L) chain genes. To determine whether the predicted g---~, hierarchy was occurring in 
vitro, we generated Epstein-Barr virus-transformed cell lines from cultures undergoing human 
pre-B cell differentiation. A total of 143 cell lines were established. 24 expressed cell surface tz/~, 
by flow cytometry  and were clonal by Southern blotting. Surprisingly, two of the/z/~,-expressing 
cell lines contained both g alleles  in germline configuration, and synthesis/expression  of  conventional 
~, L chains was directly proven by immunoprecipitationAodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) in one of them. Thus, human fetal bone marrow B lineage cells 
harbor the capacity to make functional ~ L chain gene rearrangements without rearranging or 
deleting either x allele. A third unusual cell line, designated 30.30, was observed to coexpress 
cell surface g and X L chains associated  with/~ H chains. The 30.30 cell line had a diploid karyotype, 
a  single  H  chain rearrangement, both  K alleles rearranged,  and  a  single  ~  rearrangement. 
Immunoprecipitation/SDS-PAGE  confirmed that 30.30 cells synthesized and expressed g and 
X L chains. Multiparameter flow cytometry was used to demonstrate the existence of K+/X + 
cells in fetal bone marrow and fetal spleen at frequencies of 2-3% of the total  surface Ig + B 
cell population.  The flow cytometry data was confirmed by two-color immunofluorescence 
microscopy. The existence of normal human B cells expressing cell surface K and ~ refutes the 
widely accepted concept that expression of a single L chain isotype is immutable.  The g+/X + 
cells may represent  transients  undergoing L chain isotype switching. 
I 
g gene rearrangement during mammalian B cell develop- 
ment generally follows an ordered progression beginning 
with H chain genes, and proceeding to K  and then X L chain 
genes (1-3). The outcome of a functional rearrangement at 
both H  and L chain loci is an immature B cell expressing 
a clonotypic cell surface Ig receptor. Functional  rearrange- 
ments of H and L chain genes are probably essential for sur- 
vival of most developing B cells, since surface Ig- B lineage 
cells with nonfunctional Ig gene rearrangements have never 
been found in secondary lymphoid tissues. Functional Ig gene 
rearrangements and  subsequent  differentiation  of B  cell 
precursors are regulated by recombination activating genes 
1 and 2  (RAG-1  and -2) 1 (4),  and external  factors  (e.g., 
cytokines and B cell precursor-stromal cell interactions)  in 
the bone marrow microenvironment (5, 6).  A number of 
1Abbreviations used in  this paper: Pl,  propidium  iodide;  RAG-l, 
recombination activating gene 1. 
studies have also suggested that/~ H chain proteins can regu- 
late Ig gene rearrangement, through both suppression of con- 
tinuing H chain gene rearrangement, and activation of  L chain 
gene rearrangement (7,  8). 
Although the H chain --~ x L chain ~  ~ L chain hierarchy 
is the predominant rearrangement sequence during B cell de- 
velopment, exceptions  have been described.  For example, 
Kubagawa  et  al.  (9)  characterized  four EBV-transformed 
human fetal bone marrow (FBM) pre-B cell lines that syn- 
thesized K  L chains, but no # H chains. Two of the four had 
both H chain alleles in germline, indicating that H chain gene 
rearrangement and expression is not an absolute requirement 
for x L chain gene rearrangement and expression. Exceptions 
to the ~--~, hierarchy have also been reported. Several  mouse 
cell lines have been described with functional S rearrange- 
ments and both x alleles in germline (10, 11), as have rare 
cases of human leukemic cells with ~ rearrangements  and 
germline ~ alleles (12, 13). 
We have developed a short-term culture that supports func- 
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normal human pre-B cells in vitro (14). As part of an effort 
to determine whether the conventional r -~ X rearrangement 
hierarchy was occurring in vitro, we generated EBV trans- 
formants from cultures undergoing pre-B cell differentiation. 
Several of these cell lines are shown to manifest patterns of 
L chain gene rearrangement and expression that have not been 
described in human B cell development. Evidence is presented 
that normal, nontransformed human B cells coexpressing cell 
surface r  and  X L  chains  exist  in vivo. 
Materials  and  Methods 
Cells.  Cells were isolated from 18-21-wk gestational age human 
fetal bone marrow in accordance with the guidelines of the Univer- 
sity of Minnesota Committee on the Use of Human Subjects in 
Research.  CD10 § Aurface L chain- B cell precursors were isolated 
by magnetic bead depletion as described in detail elsewhere (14, 
15). This enriched B cell precursor population (90-95% CD19 + 
cells) contained ,,~30% cytoplasmic/~- pro-B cells, and •70%  cy- 
toplasmic # + pre-B cells. After magnetic bead depletion, the cell 
viability was 99% as assessed by trypan blue exclusion.  The en- 
riched CD10 §  L chain- cells were resuspended  in RPMI- 
1640, 10% FCS, 100 U Penicillin/m1, and 100/~g streptomycin/ml 
(complete medium) at a concentration of 106 cdls/ml. They were 
immediately transformed with EBV (day 0) as described below, or 
incubated at 37~  5% CO2 for 1 or 3 d before EBV transforma- 
tion (day 1 or 3). Viability of the CD10+/surface L chain- cells 
cultured for 1-3 d was 66-84%. In some experiments, the entire 
fetal bone marrow B lineage population was isolated  by leaving 
out the anti-/~ mAb in the magnetic bead depletion. These cells 
were used to determine whether B cells coexpressing r  and X L 
chains exist (see below). 
Fetal spleen cell suspensions were prepared by pressing small pieces 
of tissue through a sterile, stainless steel mesh. Mononuclear cells 
were isolated by Ficoll-Hypaque centrifugation, and the adherent 
cells were depleted by a 1-2-h incubation on plastic tissue culture 
flasks. T  cells were then eliminated by magnetic bead depletion 
using anti-CD2 and -CD7 mAb.  The resulting population was 
>95%  CD19 +. 
Antibodies.  Hybridoma cells obtained from the American Type 
Culture Collection (Rockville, MD) were used to produce murine 
mAb recognizing human  /~ H  chains  (HB57),  and  r  L  chains 
(HB61). HB61 was directly conjugated to FITC for use in some 
experiments (16). The mAb were purified from ascites using stan- 
dard protein A-Sepharose chromatography (Pharmacia  LKB Bio- 
technology, Piscataway, NJ). F(ab')2 goat anti-human r-FITC and 
F(ab')2 goat anti-human X-PE were used as a dual staining cock- 
tail in two-color flow cytometry along with control F(ab')2 goat 
Ig conjugated to FITC and PE. These reagents were purchased 
from Tago Immunologicals (Burlingame, CA). Goat anti-human 
~-FITC and goat anti-human X-tetramethyl-rhodamine isothio- 
cyanate (TRITC) were purchased from Southern Biotechnology 
Associates, Inc. (Birmingham, AL), as were unconjugated and bio- 
tinylated mouse anti-human )~ (product 9180-01 and 9180-08) used 
in immunofluorescence and immunoprecipitation assays. Murine 
IgG1 myeloma protein (Cappel Products, Durham, NC) was FITC 
conjugated or biotinylated using standard  methods (16).  Strep- 
tavidin-PE was purchased from Caltag Laboratories (South San Fran- 
cisco,  CA). 
Iraraunofluorescent Stainin~ Flow Cytometry, and Fluorescence Mi- 
crosco~.  Cells were washed twice with fluorescence buffer (PBS, 
2.5% newborn calf serum, 0.02% NAN3) and stained with F(ab')2 
goat anti-human r-FITC and ~-PE for 20-30 min on ice. Con- 
trols consisted of F(ab')2 goat Ig conjugated to FITC or PE. An 
alternative staining protocol used mouse anti-human r-FITC and 
biotinylated mouse anti-human ~ plus streptavidin-PE. Controls 
in this protocol were mouse IgG1-FITC and biotinylated mouse 
IgG1. Cells were washed twice in fluorescence buffer and fixed in 
1% paraformaldehyde before analysis on a FACScan  |  using Con- 
sort 30 software (Becton Dickinson & Co., Mountain View, CA). 
Some  experiments  incorporated propidium  iodide  (PI)  (Sigma 
Chemical Co., St. Louis, MO) to electronically  gate out nonspecific 
fluorescent staining of dead cells. Cells in these experiments were 
not fixed in paraformaldehyde. A FACStar  ~ equipped with the FAC- 
Star PLUS  |  Pulse Processing Option (Becton Dickinson & Co.) 
was used to measure the pulse width of forward angle light scatter 
(17), in order to formally exclude cell doublets from some analyses. 
Potential Fc receptor bound Ig was disassociated by washing the 
cells in pH 4.0 acetate buffer for 1 min at 4~  (18). 
Immunofluorescence microscopy was used to directly analyze 
normal B lineage cells for coexpression of cell surface r  and ~, L 
chains.  CD10 §  fetal  bone marrow  B  lineage  cells  (containing 
"~25% B cells expressing cell surface r and ),) were stained on ice 
for 30 min with saturating concentrations of goat anti-human 
r-FITC and goat anti-human  ~-TRITC, washed three times in 
fluorescence buffer, and fixed in 1% paraformaldehyde.  Fixed cells 
were cytocentrifuged onto microscope slides, and cell dots were 
mounted in  one drop of 1 mg/ml p-phenylenediamene (Sigma 
Chemical Co.) in pH 8.0 glycerol. The slides were examined using 
a fluorescent microscope (Zeiss, Obercochen, Germany) equipped 
with ploem epiilumination and selective barrier filters to distin- 
guish  green and red fluorescence.  ASA  400 film  (Ektachrome; 
Eastman Kodak, Rochester, NY) was used for phase/fluorescent 
photomicrographs. 
EBV Transformation and Culture Conditions.  CD10 +/surface  L 
chain- calls were incubated at 37~  5% COs for 3 d with EBV 
obtained from culture superuatants of the B95-8 marmoset cell 
line. Cells were then cultured in complete medium in 96-well mi- 
crotiter plates (Costar, Cambridge, MA) containing 4,000 or 10,000 
irradiated (6,000 rad) fetal bone marrow fibroblasts. Seeding densi- 
ties ranged from 10 to 10  s B cell precursors/well. One half of the 
culture supernatant was replaced  twice weekly with fresh com- 
plete medium.  Stable EBV transformants emerged in 2-4 mo. 
Southern Blotting.  Ceils were digested at 37~  for 18 h in TNE 
(10 mM Tris, pH 8.0, 100 mM NaC1, and I mM EDTA, pH 8.0), 
2  mg/ml  proteinase K,  and  1%  SDS.  DNA  was  extracted in 
"~6 M NaC1,  and precipitated in 2 vol of cold absolute ethanol. 
Dry DNA pellets were dissolved in 50-100/~1  TE (10 mM Tris, 
pH 7.6 and  1 mM EDTA, pH 8.0),  and digested with EcoRI, 
BamHI, or BamHI-HindlII (GIBCO BRL, Gaithersburg, MD) 
for 4-5 h at 37~  2-10/~g of DNA were loaded per lane of a 
0.6 or 0.8% agarose gel and electrophoresed in TBE (0.089 M Tris, 
0.089 M boric add, and 0.002 M EDTA). Transfer of DNA to nylon 
membranes (GeneScreenPlus;  NEN  Research Products, Boston, 
MA)  was  facilitated  by 10x  SSC  using vacuum blotting with 
PosiBlot  |  (Stratagene,  La Jolla, CA) following the manufacturer's 
protocol. The membrane was dried at room temperature or UV 
crosslinked  using 1,200,000 joules (UV crosslinker;  Stratagene). 
Membranes  were prehybridized in  10%  dextran sulfate  (Sigma 
Chemical Co.), 1% SDS, and 1 M NaCI. Hybridization was con- 
ducted at 65~  for 18 h  with o~-~2[P]dCTP-labeled probes (see 
below). The membranes were washed sequentially with 2x  SSC, 
0.5% SDS at room temperature for 10 min; lx  SSC, 0.5% SDS 
at 63~  for 15-30 min; and, when needed, 0.1x  SSC, 0.5% SDS 
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wash with 2 x SSC at room temperature for 10 rain before autora- 
diography using X-Omat AP, film (Eastman Kodak) at  -70~ 
Exposure times ranged from 3 to 5 d. 
Probes were labded with cz-[32p]dCTP to sp act of ~2.0  x  109 
dpm//~g using random sequence hexanudeotide primers in a DNA 
polymerase I (Klenow fragment) catalyzed  reaction (19), according 
to the manufacturer's  recommendations  (Multiprime  DNA Labeling 
Systems; Amersham Corp., Arlington Heights, IL). Four probes 
were used to assess the status of the Ig genes; a 0.8-kb germline 
BamHI-HindIII fragment containing the Cxl gene (20), a 2.5-kb 
germline EcolLI  CK probe (21), a 2.5-kb HindIII-BamHI fragment 
of the x deleting element (Kde) (22, 23), and a 2.4-kb Sau3a genomic 
J. fragment (24). 
Biosynthetic Labeling, Immunoprecipitation,  and SDS-PAGE.  Log 
phase cells were biosynthetically labeled for 3 h at 37~  with 
t-[3SS]cysteine (Amersham Corp.)  as previously described (25). 
Labeling was halted by three washes in cold PBS, and the cells  were 
lysed in 0.1 M Tris (pH 8.1), 0.9% NaC1, 0.5% NP-40 (Particle 
Data Inc., Elmhurst, IL), 1 mM EDTA, 1% aprotinin, 1.0/~g/ml 
leupeptin, 0.7/~g/ml pepstatin, and 2 mM PMSF (Sigma Chem- 
ical Co.). Debris was pelleted by centrifugation at 10,000 g for 30 
rain at 4~  Lysates  from biosynthetically labeled cells were pre- 
cleared twice (2 h and overnight) with 10% protein A-Sepharose 
CL-4B (Pharmacia LKB Biotechnology) at 4~  50/~1 aliquots of 
precleared lysate were incubated with 25 #g of purified antibody 
for 3 h at 4~  Immune complexes were precipitated with 75/~1 
of 10% protein A-Sepharose containing 1 mg/ml BSA for 1 h at 
4~  and washed four times in lysis  buffer containing 0.5% deoxy- 
cholate (Sigma Chemical Co.). Immune complexes were eluted, 
reduced in sample buffer (80 mM Tris, pH 6.8, 3% SDS, 15% 
glycerol, 0.01% bromophenol blue, and 5% 2-ME), and resolved 
on 13% SDS-PAGE  gels. Gels were submerged in Amplify (Amer- 
sham Corp.) for 30 rain and visualized using Kodak X-Omat AlL 
film at  -70~ 
Results 
Characterization of  In Vitro Differentiated Pre-B Cells Rescued 
by EBV Transformation.  We have described a short-term cul- 
ture that supports functional L chain gene rearrangement and 
differentiation of normal human pre-B  cells (14). To deter- 
mine whether the conventional x---X rearrangement hierarchy 
was occurring in vitro, we generated EBV transformants from 
cultures undergoing pre-B cell differentiation. CD10+Aur  - 
face L chain-  B cell precursors containing 60-70%  pre-B 
ceUs were isolated from six donors and cultured for 1 or 3 d. 
As shown in Table 1, L chain gene rearrangement and ex- 
pression occurred in all six. Consistent with our previous 
findings (14),), expression predominated over K in four of 
the six cultures (Table 1). EBV transformation of these six 
cultures, as well as fresh CD10+/surface L chain- cells iso- 
lated from three of the donors, culminated in the establish- 
ment of 143 cell lines.  Two-color flow cytometric analysis 
revealed that 38 of the 143 cell lines expressed  cell surface 
X L chains.  24 of these cell lines were clonal by Southern 
blotting utilizing J., C~, xde, and Cx probes.  21 of the 24 
X-expressing  donal cell lines had rearranged the K locus, as 
would be predicted from earlier studies (1-3, 26). Of the 21, 
15 had both K alleles deleted, three had one x aUde deleted 
and the other in germline, two had one g allele rearranged 
Table  1.  Percent  Analysis of/c and h  L  Chain Cell Surface 
Expression on CDlO+/Surface L  Chain- B Cell Precursors 
Before and After Culture 
Day0  Day 1or 3 
Sample No.  g+  )C  g+  ~,+ 
% 
FBM-28  0*  2  13  22 
FBM-30  0  1  6  14 
FBM-34  3  5  10  10 
FBM-35  1  1  9  21 
FBM-36  1  2  13  19 
FBM-41  1  0  14  12 
CD10 +/surface L chain- B cell precursors were isolated  as described in 
Materials and Methods,  and analyzed  for expression  of cell surface  ir and 
by two-color flow cytometry. The  cells were then cultured in 
RPMI-1640/10% FCS for 1 or 3 d, and reanalyzed  for expression of 
cell surface ~ and ~. 
* Percentage of x (or),) positive  cells calcuhted  by subtracting  background 
staining. 
and the other in germline, and one had both g alleles rear- 
ranged. Three cell lines (35.30, 36.31, and 30.30)  had unex- 
pected patterns of  L chain rearrangement-expression,  and were 
studied in greater detailed. 
Identification of  A-Expressing EBV-transformed Cell Lines That 
Retain  Gem, line/c Genes.  The EBV-transformed cell lines 
35.30 and 36.31  demonstrated a unique pattern of L chain 
gene rearrangement: their X genes were rearranged but their 
K genes were germline. These cell lines were derived from 
independent donors, with 35.30 established  from the fresh 
CD10 +/surface L chain- ceUs of FBM-35, and 36.31 estab- 
lished from the day 1 culture of FBM-36. On repeated two- 
color flow cytometric analyses, both cell lines expressed cell 
surface X (>64%) with no cell surface K (Fig.  1). Southern 
blots performed on DNA isolated from cell line 36.31  are 
shown in Fig. 2. A donal H  chain gene rearrangement was 
detected as a single 3.8-kb BamHI-HindlII fragment. The 
clonality of 36.31 was also supported by additional Southern 
blotting of BamHI-digested DNA hybridized with the JR 
probe  (data  not  shown).  CK  and  ~de  were  in  germline 
configuration. The 36.31 ceU line had a single ll.0-kb ), rear- 
rangement (Fig. 2), consistent with the flow cytometric data 
in Fig. 1. Therefore, 36.31 cells have a functional X rearrange- 
ment, with no evidence of rearrangement or deletion of CK. 
The 35.30 cell line differed only by the presence of two ), 
rearrangements (data not shown). Metabolic labeling with 
t-[3SS]cysteine and immunoprecipitation provided direct evi- 
dence that 36.31 cells synthesized # H chains and X L chains 
(Fig.  3).  The presence  of a 29-kD  X L chain (Fig.  3)  also 
diminated the possibility that our results could be explained 
by the synthesis of surrogate X L chains, which have molec- 
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Figure  1.  Surface  L chain expression  of  EBV-transformed  cell lines 35.30 
and 36.31. Representative two-color  flow cytometric analyses, utilizing 
F(ab')2 goat anti-human g-FITC and )~-PE, reveal  that cell line 35.30 con- 
tains 64% )~+ cells (top left),  and cell line 36.31 contains 76% X  + cells 
(top right).  (Bottom)  Results of staining with preimmune F(ab')2 goat Ig- 
FITC and -PE. Events appearing in the double L chain  + (top right) quad- 
rants are likely due to nonspecific fluorescence of dead cells. 
ular weights of 16,000,  18,000, and 22,000 (26-28). Cell line 
35.30 was lost in culture, and could not be examined for )~ 
L  chain synthesis. 
Identification of  an EBV-transformed Cell Line That Coexpresses 
/c and A  L  Chains.  A  highly unusual call line, designated 
30.30, was identified while screening the 143 EBV-transformed 
cell lines for surface L chain expression. This cell line origi- 
Figure 3.  SDS-PAGE analysis 
(reducing conditions) of imratmo- 
precipitated ~ and ~, proteins from 
t-[3sS]cysteine metabolically  la- 
beled 36.31 cells. (Left) The rela- 
tive  molecular  mass (kD)  of 
protein  standards.  Lysates im- 
munoprecipitated  with  purified 
mouse  IgG1  myeloma  protein 
served as a control. Exposure time 
was 3  d. 
nated from the day 1 culture of FBM-30,  and initial two- 
color flow cytometric analysis revealed that 49% of the cells 
coexpressed x and X L chains (Fig. 4). Identical staining results 
were obtained  using  FITC  and biotinylated mouse mAb 
against x and ~, L chains (data not shown). 30.30 cells have 
a normal diploid karyotype and express the following pheno- 
type:  CD5 +,  CD7-,  CD10-,  CD19 +,  CD20 +,  CD21 +, 
CD23 + , and CD40 + . Attempts to isolate a stable popula- 
tion of ~c+/), + cells by FACS  |  have been unsuccessful, with 
sorted K+/)x + cells reverting to a mixed Ic+/), + and K+/~, - 
phenotype after several weeks in culture. 
Figure 2.  lg gene rearrangements in 36.31 cells as- 
sessed by Southern blot analysis using DNA digested 
with the indicated restriction  endonucleases and hy- 
bridized with probes spedfic for Cx, gde, Cx, and J, 
genes. All analyses utilized DNA isolated from EBV- 
transformed cell lines derived from FBM-36, with the 
exception of the fibroblast DNA in the first lane of 
the J. blot, which was used to define the germline 
J. fragment size. (Left) Germline fragments  defined 
on the original blot with fibroblast DNA. The 2.5- 
kb strongly crossbybridizing fragment present in all 
lanes of the Kde blot does not map to the Kde locus 
(30). The crossbybridizing 5-kb fragment present in 
all lanes of  the C~ blot maps to a psendogene on chro- 
mosome 18 01). (Arrows)  All  rearrangements. Cell line 
36.23 contains K  and ~ genes in gerraline, and serves 
as a )~ germline control to define )~ rearrangements 
in 36.20 and 36.31. Cell line 36.20 DNA typifies a 
conventional  ~,=expr~sing  cell line  that has deleted  both 
K alleles, and rearranged both Kde alldes ('~8.4 and 
9.5 kb), both )~ alleles (•2.4  and 5.5 kb), and both 
H chain alleles (,,o3.5 and 4.0 kb). Identical amounts 
of DNA were loaded per lane in each blot, except in 
the J, blot where 5 ~g were loaded in the first two 
lanes and 2.5 ~tg in the last two lanes. 
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Figure 4.  Two-color  flow cytometric  analysis 
showing K/X coexpressing  30.30 cells. Cells  were 
stained with prdmmune  F(ab')2  goat Ig-FITC  and 
-PE (A-C) or F(ab')2 goat anti-human K-FITC 
and  X-PE (D-F). EBV-transformed cell lines 
demonstrating  Ic (30.1; 94% x  +) or ~, (2.4; 91% 
~+) surface  L chain  expression  were used as com- 
pensarion controls. The 30.30 cell line contained 
49% x+/~,+ cells and 45% g+/X- cells. Over a 
1-yr period the percentage of x  §  cells ranged 
from 22 to 58%. 
Southern blot analyses of DNA from 30.30 cells showed 
both K alleles rearranged ('~7.5 and 10.5 kb), both gde in 
germline, a single "~8.5-kb X rearrangement, and a single 
'~4.8-kb H  chain rearrangement (Fig.  5). A single H  chain 
rearrangement was also detected using BamHI-digested DNA 
(data not shown). Rearrangement of a single H chain allele 
must represent the functional VDJ rearrangement encoding 
the/z H chain, and provides strong evidence that 30.30 cells 
are clonal. 
I.-[3SS]cysteine labeling and immunoprecipitation was un- 
dertaken to directly examine whether 30.30 cells synthesized 
K and X L chains. As shown in Fig. 6, the ,~,75-kD # H chain 
was immunoprecipitated with antibodies against #, g, and 
X. A ,,o29-kD x L chain was immunoprecipitated with anti-c, 
a *28-kD X L chain was immunoprecipitated with anti-X, 
and both L chains were immunoprecipitated with anti-#. The 
weak ,,o29-kD protein in the anti-X lane and a barely visible 
,,o28-kD  protein in the anti-g lane may represent immuno- 
precipitation of Ig molecules containing two H  chains,  one 
ic L chain, and one X L chain. Importantly, human surrogate 
X L  chains  (27-29)  were  not  detectable in  the  anti-/z  or 
anti-X immunoprecipitates, thereby excluding the possibility 
that x L chains were coexpressed with surrogate X L chains. 
Detection of Normal/c/A  Coexpressing B  Cells.  To deter- 
mine whether a normal counterpart to the 30.30 cell line 
exists in vivo,  we performed a detailed analysis of L chain 
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Figure  5.  Southern  blot analysis 
of Ig gene rearrangement  in 30.30 
ceils. DNA isohted  from  fibroblasts, 
cell lines, 30.30 and 30.6 (a control 
~-expressing  cell line)  was digested 
with the indicated restriction en- 
donucleases and hybridized  with 
probes specific  for Cx, lode,  CX, and 
J. genes. (/.eft)  C~mline  ~gments. 
(Arrows) Rearranged fragments. Figure  6.  SDS-PAGE  analysis 
(reducing conditions) ofimmunopre- 
cipitated #,  g, and X proteins from 
[3sS]cysteine  metabolically  labeled 
30.30 cells. (Left) The relative molec- 
ular mass (kD) of protein standards. 
Lysates  immunoprecipitated  with 
purified mouse IgG1 myeloma protein 
served  as  a  control.  Exposure  time 
was 6  d. 
expression on human fetal bone marrow and splenic B cells. 
Three-color analysis  was used to assess whether ~+/X + cells 
exist in a PI-negative  (i.e.,  viable) cell population.  A  repre- 
sentative experiment  is shown in Fig.  7.  The dot plot (top 
left)  demonstrates  the  existence  of ~+/X +  cells  (Fig.  7 B) 
representing  2.5%  of the  surface Ig +  B  cells  in fetal  bone 
marrow.  Similarly,  the  spleen contained  ~+/X +  cells  (Fig. 
7 E) representing 3.1%  of the surface Ig + B cells.  Additional 
analyses  revealed  that  ~+/X +  cells comprised  2.2  _+  0.6% 
(n  =  13  experiments)  of fetal  bone marrow surface  Ig +  B 
cells  and 3.3  _+  0.6%  (n  =  4  experiments)  of fetal  splenic 
surface Ig § B cells.  Three-color staining using anti-~,  anti-X, 
and anti-CD19 confirmed that the ~+/X + cells were CD19 § , 
and therefore of B  lineage  origin  (data  not  shown).  Fig.  7 
also shows the forward and side (90 ~  ) light scatter properties 
of the k +,  ~+/X+,  and ~+  populations.  The identical light 
scatter  properties  (particularly  forward light  scatter  which 
is a direct measurement of cell size) of each of the three popu- 
lations  suggests  that  the  ~+/X +  population cannot be ex- 
plained  as  cell  doublets.  The  possibility  that  the  ~+/X + 
population reflected  a cell doublet artifact  was formally ex- 
cluded by pulse width analysis on 3 of the 13 fetal bone marrow 
donors. An analysis  of cells from one donor is shown in Fig. 
8.  The boxed ~+/X + population in Fig.  8 A  was analyzed 
for pulse width  forward light  scatter  and PI characteristics 
(Fig.  8  B).  Only  0.9%  of  the  ~+/X +  events  were  PI- 
negative doublets (top left quadrant). Similar analysis on two 
other donors, coupled with the donor in Fig. 8, revealed that 
only  0.53  -  0.58%  of the  ~+/X +  cells  had pulse  width 
profiles consistent  with cell doublets.  Importantly,  analysis 
of the rare PI-negative doublets in the total B lineage popu- 
lation  (Fig.  8  C,  top  left)  revealed  a  random  distribution 
amongst  the  x-IX-,  K+/X -,  K-IX +  populations  (Fig.  8 
D).  Treatment of fetal bone marrow B  cells with  a pH 4.0 
acetate buffer wash also  had no effect  on  the coexpression 
of g  and )~ L  chains  (data  not  shown). 
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Figure  7.  Three-color flow cytometric analysis of donor-matched normal 
fetal bone marrow and splenic B cells demonstrates x/X cocxpression.  The 
left column contains  dot  plots  of the  total  CD10+/CD19 *  population 
of fetal bone marrow and spleen cells stained with F(ab')2 goat anti-human 
~-FITC and X-PE, or preimmune F(ab')2  goat  Ig-FITC  and -PE.  Only 
PI-  events  collected  within  the  lymphoid  gate  are  shown.  Fetal  bone 
marrow X + cells  (A) represent  16%; K+/X  + cells (B) represent 1.2%; and 
K  + cells (C) represent  13% of the total B lineage population.  Fetal  splenic 
X + cells (D) represent  34%; K+/X + (E) represent 2.9%; and ~+  (F) rep- 
resent  59%  of the total  B  lineage population.  (Right) Forward  and side 
(90  ~  light scatter  characteristics  of the fetal bone marrow and spleen X + 
(A and D), K*/X  + (B and E), and K  + (C and F) populations.  The light 
scatter  mean channel values for the three fetal bone marrow B cell popula- 
tions were:  X + (FSC-420, 90~  x+/X + (FSC-427, 90~  and K  + 
(FSC-434,  90~  The  analogous  splenic values  were:  X +  (FSC-486, 
90~  K+/X +  (FSC-514, 90~  and ~+  (FSC-489,  90~ 
144  Coexpression  of K and  X  Light  Chains  on  Human  B  Cells A  ￿9  ~ 
i:i!ki:!i:~i 
Anti-K-F1TC 
B 
Propldium Iodide 
i  C 
Propldium Iodide 
D 
i I:  i: 
Anti-K-FITC 
Figure 8.  A representative analysis of the pulse width measurements 
made on the forward  light scatter  of x+/X + fetal bone marrow cells 
demonstrates that detection of this rare cell type cannot be explained by 
a cell doublet artifact. Three-color  multiparameter  analysis of fetal bone 
marrow  B lineage cells stained with PI and F(ab')a goat anti-human 
~-FITC and )~-PE (A) showed 0.1% of the total B cell population were 
K+/~ + in this experiment.  When pulse width analysis of the forward 
light scatter events was performed on the K+/X + population (box, A), 
89%0 of the events represented viable single cells (B, bottom left).  The re- 
maining events were distributed as follows: 0.9% Pl-  doublets (B, top 
left), 0.9%  PI + doublets  (13, top right),  and 9.2%  PI + single cells (B, 
bottom right). Pulse width analysis of the total B lineage population in A 
is presented in C. This provides a clear definition of the electronic gating 
used to define viable single cells (bottom left) and cell doublets (top left). 
(/9) K and )~ distribution of the viable cell doublets identified in the top 
left quadrant  of C. 
Fig. 9, B and C shows an example of a K+/)~ § fetal bone 
marrow B cell detected by two-color immunofluorescence 
microscopy.  Also  shown are g+/)~-,  K-/)~ +,  and K-/)~- 
lymphocytes. The intense fluorescent staining of the K  +/)~ + 
cell confirms the flow cytometry data shown in Fig. 7. Similar 
results were obtained when fetal splenic B cells were ana- 
lyzed (data not shown). 
Discussion 
In a study published several years ago, we observed that 
normal human pre-B ceils that differentiate in vitro give rise 
to a higher percentage of immature B cells expressing surface 
/~/)x than surface/~/K (13).  A possible explanation for this 
data is that some pre-B cells make functional ), rearrange- 
ments directly, and bypass x rearrangements altogether. Studies 
originally reported by Korsmeyer et al.  (26) and Hieter et 
al. (32) suggested an ordered progression (hierarchy) of K'->)~ 
rearrangement in human B ceils, an observation consistent 
with studies in the mouse (for a review see reference 3). The 
K--*)~ hierarchy is, nonetheless, not absolute. Several mouse 
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cell lines have been described with functional )~ rearrange- 
ments and both x alleles in germline (10,  11), and analyses 
of human cells also suggest that )~ rearrangement can pre- 
cede K (12,  13). However, the studies of human cells did not 
resolve whether the )~ rearrangements gave rise to )~ L chains. 
In the current study, EBV transformation was used to rescue 
the differentiated progeny of pre-B cells, and transformants 
expressing #/)~ surface Ig receptors were examined for their 
K gene rearrangement status. Using this approach, we pro- 
duced and characterized two cell lines, designated 35.30 and 
36.31, both containing functional )~ rearrangements with K 
alleles  in germline. The germline status of the g alleles in 
both cell lines was confirmed by the absence of detectable 
rearrangements of the gde alleles.  The H  chain rearrange- 
ment profile was consistent with donality in both cell lines, 
and synthesis/expression of ;k L chains was directly demon- 
strated in 36.31 cells (Fig. 3). These collective results provide 
direct evidence that nonleukemic human fetal bone marrow 
B lineage cells harbor the capacity to make functional )x L 
chain gene rearrangements without rearranging or deleting 
either x allele. 
It is conceivable that 36.31 and 35.30 arose from fetal bone 
marrow B lineage cells containing germline X genes, and X 
rearrangements  occurred  after  expansion  of  the  EBV- 
transformed done in vitro. Yet, additional Ig gene rearrange- 
ments and isotype switching are rarely observed after EBV 
transformation (9, 33, 34).  Rearrangement of the Kde (or 
recombining sequence as it has been called in the mouse) has 
been proposed as a mechanism that serves to initiate )~ rear- 
rangement (23, 35, 36). However, studies comparing the Ig 
gene rearrangement status of short- versus long-term EBV- 
transformed cell lines (26, 32), and studies done with a mu- 
fine myeloma (10),  suggest that deletion of Cx can occur 
after k rearrangement has been initiated. It is therefore pos- 
sible that 36.31 and 35.30 represent cells rescued by EBV be- 
fore rearranging or deleting one or both K alleles. 
The notion that expression of a single L chain isotype is 
stringently imposed at the level of individual mature B cells, 
first demonstrated in human cells by Bernier and Cebra (37, 
38), is a widely accepted concept in immunology. Sporadic 
reports have appeared suggesting that exceptions to the single 
L chain isotype rule may exist in human B cells. Human my- 
eloma cells coexpressing cytoplasmic x and )~ L chains have 
been described (39-41), as has a single case of acute lympho- 
blastic leukemia (42). However, none of these studies provided 
immunochemical evidence that the myeloma cells synthesized 
and expressed K and )~ L chains. The results presented in this 
report provide solid evidence that human B cells exist which 
coexpress g and )~ L chains on the surface of a single cell. 
The EBV-transformed cell line 30.30 provided the initial clue. 
Two-color flow cytometry revealed a major population of 30.30 
cells coexpressing g and )~ L chains (Fig. 4). Southern blot- 
ting revealed that 30.30 had a single H chain rearrangement, 
both K alleles rearranged, both gde alleles in germline, and 
one ~ rearrangement (Fig. 5). Direct evidence that 30.30 cells 
synthesize and express g and )~ L chains was demonstrated 
by biosynthetic labeling and immunopredpitation/SDS-PAGE 
(Fig. 6). Efforts to isolate a stable, pure population of 30.30 Figure 9.  Detection of K+ /)~  + cells in normal fetal 
bone marrow by two-color immunofluoreseence mi- 
croscopy. Cells were isolated, stained, and analyzed 
as described in Materials and Methods. A single field 
of cells is visualized by phase contrast (,4) or fluores- 
cence (B, FITC; C, TRITC) mioroscopy. (V) The 
K§  + cell. (-~) One K+IX - and two K-IX + cells. 
Note also the presence of small lymphoid cells that 
do not stain for K or ~ (K-/X-  cells). cells coexpressing K and ~ L chains by FACS  |  were unsuc- 
cessful, and repetitive two-color flow cytometry consistently 
showed the fluorescence profiles presented in Fig. 4. The con- 
stant presence of a ~,-  population is in some discord with 
the immunoprecipitation data (Fig. 6) suggesting that ~, L 
chains are synthesized at a faster rate and/or are more stable 
than KL chains. It is conceivable that all 30.30 cells express 
L chains, but the amount which exists as/~/)~ cell surface 
Ig is variable. Similarly, xL chains may form more stable com- 
plexes with/~H  chains than RL chains. 
The  establishment  and  characterization  of the  x+/X § 
30.30 cell line prompted us to search for the existence of a 
normal in vivo counterpart. The data presented in Figs. 7-9, 
provide strong evidence that x +/~+  human B ceils exist in 
fetal  bone  marrow  and  spleen.  The  possibility  that  the 
K§  + population is an artifact attributable to dead cells, 
cell doublets, or passively (Fc receptor) adsorbed Ig was elim- 
inated by propidium iodide gating to eliminate dead cells, 
pulse  width  analysis  to  eliminate  cell doublets,  and  acid 
washing and 37~  incubation to eliminate potential passively 
adsorbed Ig. Most importantly, the flow cytometry data was 
confirmed by two-color immunofluorescence  microscopy. The 
existence of K+/X + ceUs can be explained in several ways. 
Pre-B cells containing g and ~, in germline could simultane- 
ously undergo functional Jc and ), V toJ rearrangements, giving 
rise to x +/X + cells. This developmental scenario would as- 
sume that the recombinase ensemble (e.g., RAG-1 and -2) 
would have equal access to the heptamer-nonamer recogni- 
tion sequences in both x and )~ loci. Alternatively, #+/g+ 
or ~ +/X + B cells could rearrange the alternate L chain gene 
to give rise to ~+/X + cells. Independent of how ~+/~,+ cells 
arise,  they may be transients during B cell ontogeny, in the 
process of switching L chain isotypes. The most likely pathway 
invoked by this model would be x--*gX--*X. In this pathway, 
the ultimate sole expression of )~ might occur after K dele- 
tion by the Kde. Support for a K-*xX--*X pathway can be 
found in the study by Gollahon et al.  (43),  who observed 
~, L chain expression in hybridomas generated from mice har- 
boring  a  functionally rearranged  K transgene.  They also 
presented evidence that "~20% of X + normal splenic B cells 
coexpressed gL chain, and used this data to argue the exis- 
tence of a so-called KX-B cell lineage which lacks feedback 
inhibition of L chain gene rearrangement (43).  Hardy et al. 
(44)  also described a LPS-induced call surface K  + murine 
Ly-1 + lymphoma that expressed cell surface ~  L chains. A 
X--*xX--*x pathway is also possible,  since human B cells with 
functional ~ rearrangements and germline K alleles exist in 
the form of the 36.31  and 35.30 cell lines.  Support for this 
pathway is weakened by the absence of a homologue to the 
xde in the ~, locus (45). 
Do Jc +/~ + cells subserve any function in the immune re- 
sponse? Cohn and Langman (46) have used the theoretical 
argument  that  "doubles"  (including tc+/X +  and cells  ex- 
pressing two alleles of the same L chain isotype) must exist 
to maintain the evolutionary selection pressure necessary for 
haplotype exclusion.  B  cells  undergoing L  chain  isotype 
switching could also contribute to Ig repertoire diversification 
by  (presumably)  changing  antigen  specificity.  Our  iden- 
tification of K+/X + B cells in normal fetal bone marrow and 
spleen,  coupled with  the recently described CD40/L  cell 
system for growing normal human B cells in vitro (47), may 
facilitate characterization of V. and VL usage, cytokine re- 
sponsiveness,  and antigen specificity in these unusual calls. 
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